Zim Laboratories Limited

Web: zimlab.in NSE: ZIMLAB BSE: 541400 SECTOR: Healthcare - Pharmaceuticals & Biotechnology | Add Note | View Notes

127 1(-1%)

Near 52W High of 134

Volume

1L as on 23, Jun

Open

114

High

115

Low

111

128

VWAP

124

52 Week High

134

52 Week Low

Viand Research Rating

Quality Score

5/100

Growth Score

15/100

Valuation Score

50/100

Momentum Score

20/100

Analyst Recommendations

BUY/SELL

Hold | Buy | Strong Buy

Analyst Price Target

Market Cap (cr)

683

No. of Shares

5.37

P/E

36.37

P/B

2.3

Face Value

Div. Yield

Book Value (TTM)

CASH

DEBT

EPS (TTM)

ROE

6.34

ROCE

Profit Growth

Listing Date

25-Nov-22

Promoter Holding

30.36%

FII Holding

0.03%

DII Holding

1.34%

Price Chart

Price Performance

1 Week9%

1 Month22%

3 Months22%

6 Months22%

1 Year22%

YTD22%

Moving Average

5 Day SMA118

10 Day SMA115

20 Day SMA110

30 Day SMA0

50 Day SMA0

61 Day SMA0

80 Day SMA0

200 Day SMA0

PIVOT LEVEL

	Standard	Camarilla	Fibonacci	Woodie's
Resistance 3	141	129	133	146
Resistance 2	133	127	129	136
Resistance 1	129	126	126	135
Pivot Point	122	125	122	124
Support 1	118	124	117	124
Support 2	110	123	115	113
Support 3	106	122	110	112

Competitors/Peers

#	Symbol	MCAP	LTP	1W	1M	6M	1Y	P/E	Ind PE	Debt/Eq	NP Qtr Rs.Cr.
1	SUNPHARMA	4,56,655	1899	0%	2%	9%	21%	37	57.7	0.07	11509
2	DIVISLAB	2,43,196	9161	2%	8%	44%	51%	69	57.7	0	2568
3	TORNTPHARM	1,84,303	4846	2%	3%	12%	36%	72	57.7	1.79	2138
4	APOLLOHOSP	1,24,834	8650	1%	1%	12%	10%	58	57.7	0.9	2003
5	ZYDUSLIFE	1,12,897	1132	4%	2%	26%	13%	20	57.7	0.46	5124
6	CIPLA	1,11,346	1385	2%	5%	3%	12%	22	57.7	0.02	3862
7	LAURUSLABS	99,634	1844	3%	3%	75%	114%	0	57.7	0.48	890
8	DRREDDY	96,962	1151	2%	2%	11%	8%	20	57.7	0.2	4158
9	MAXHEALTH	96,646	985	1%	10%	8%	14%	0	57.7	0.32	1442
10	LUPIN	96,620	2113	1%	11%	8%	10%	23	57.7	0.29	5355
Load More

Shareholding Pattern (%)

	Jun 2026	Mar 2026	Dec 2025	Sep 2025	Jun 2025	Mar 2025	Dec 2024	Sep 2024	Jun 2024	Mar 2024	Dec 2023	Sep 2023	Jun 2023	Mar 2023	Dec 2022	Sep 2022	Jun 2022	Mar 2022	Dec 2021	Sep 2021
Promoters	(0.01) 30.36%	(-2.91) 30.35%	(0.01) 33.26%	(0.01) 33.26%	(0.01) 33.26%	(0.01) 33.26%	(0.01) 33.26%	(0.01) 33.26%	(0.01) 33.26%	(0.01) 33.26%	(0.01) 33.26%	(0.01) 33.26%	(0.01) 33.26%	(0.01) 33.26%	(0.01) 33.26%	(0.01) 33.26%	(0.01) 33.26%	(0.01) 33.26%	(0.01) 33.26%	(0.01) 33.26%
FIIs	(0.01) 0.03%	(0.01) 0.00%	(0.01) 0.02%	(0.01) 0.00%	(0.01) 0.03%	(-0.21) 0.01%	(0.21) 0.21%	(0.01) 0.00%	(0.01) 0.00%	(0.01) 0.01%	(0.01) 0.00%	(-0.11) 0.00%	(0.11) 0.06%	(0.01) 0.00%	(0.01) 0.00%	(0.01) 0.00%	(0.01) 0.00%	(0.01) 0.00%	(0.01) 0.00%	(0.01) 0.00%
DIIs	(1.31) 1.34%	(-0.11) 0.07%	(0.01) 0.20%	(0.01) 0.24%	(0.01) 0.24%	(0.01) 0.24%	(0.21) 0.24%	(0.01) 0.00%	(0.01) 0.00%	(0.01) 0.00%	(0.01) 0.00%	(0.01) 0.00%	(0.01) 0.00%	(0.01) 0.00%	(0.01) 0.00%	(0.01) 0.00%	(0.01) 0.00%	(0.01) 0.00%	(0.01) 0.00%	(0.01) 0.00%
Public	68.28%	69.57%	66.52%	66.52%	66.46%	66.49%	66.29%	66.73%	66.74%	66.74%	66.74%	66.75%	66.69%	66.74%	66.73%	66.75%	66.74%	66.74%	66.74%	66.74%
No. of Shareholders	14,510	16,636	17,251	17,282	16,641	17,448	17,450	17,716	17,483	17,100	17,342	15,305	8,982	5,879	6,027	3,643	3,569	3,561	3,646	4,610

Quarterly Results

	Jun 2026	Mar 2026	Dec 2025	Sep 2025	Jun 2025	Mar 2025	Dec 2024	Sep 2024	Jun 2024	Mar 2024	Dec 2023	Sep 2023	Jun 2023	Mar 2023	Dec 2022	Sep 2022	Jun 2022	Mar 2022	Dec 2021	Sep 2021	Jun 2021
Sales	94.18	105.27	108.66	88.71	71.76	108.73	96.33	92.14	81.82	117.86	96.29	85.83	67.44	105.41	100.97	99.4	92.75	105.06	86.72	77.47	64.17
Sales Growth % (YoY)	31.2%	-3.2%	12.8%	-3.7%	-12.3%	-7.8%	0%	7.4%	21.3%	11.8%	-4.6%	-13.6%	-27.3%	0.3%	16.4%	28.3%	44.5%	42.3%	15.8%	-12%	-9%
Sales Growth % (QoQ)	-10.5%	-3.1%	22.5%	23.6%	-34%	12.9%	4.5%	12.6%	-30.6%	22.4%	12.2%	27.3%	-36%	4.4%	1.6%	7.2%	-11.7%	21.1%	11.9%	20.7%	-
Expenses	91.73	98.08	95.85	82.95	67.51	94.13	84.77	82.61	73.78	102.21	84.75	76.5	62.62	89.96	87.87	87.14	81.56	90.31	76.04	67.2	58.89
Operating Profit	2.45	7.19	12.81	5.76	4.25	14.6	11.56	9.53	8.04	15.65	11.54	9.33	4.82	15.45	13.1	12.26	11.19	14.75	10.68	10.27	5.28
OPM %	2.6	6.83	11.79	6.49	5.92	13.43	12	10.34	9.83	13.28	11.98	10.87	7.15	14.66	12.97	12.33	12.06	14.04	12.32	13.26	8.23
Other Income	0.99	6.16	1.7	2.04	1.48	1.71	1.75	1.32	1	1.53	1.11	1.42	1.12	0.69	2.4	1.42	1.89	1.63	0.68	0.87	1.22
Interest	3.64	3.31	3.43	3.16	3.3	2.91	2.73	2.89	2.86	2.28	1.7	1.22	1.73	1.27	1.62	1.36	1.33	1.43	1.75	2.58	2.55
Depreciation	5.37	5.1	5.03	4.98	4.86	5.29	4.88	5	4.94	3.91	3.94	4.09	4.03	4.93	3.9	4.37	4.27	4.18	3.83	4.36	3.66
Profit before tax	-5.57	4.94	6.05	-0.34	-2.43	8.11	5.7	2.96	1.24	10.99	7.01	5.44	0.18	9.94	9.98	7.95	7.48	10.77	5.78	4.2	0.29
Tax %	-28.01	24.29	27.27	23.53	-22.63	39.7	30	19.59	27.42	26.48	31.81	23.71	-22.22	27.16	33.87	31.45	31.15	34.73	29.76	22.38	34.48
Net Profit	-4.02	3.74	4.4	-0.42	-1.87	4.88	4	2.38	0.9	8.09	4.78	4.15	0.23	7.24	6.6	5.45	5.15	7.03	4.07	3.26	0.19
Net Profit Growth % (QoQ)	-207.5%	-15%	1147.6%	77.5%	-138.3%	22%	68.1%	164.4%	-88.9%	69.2%	15.2%	1704.3%	-96.8%	9.7%	21.1%	5.8%	-26.7%	72.7%	24.8%	1615.8%	-
Net Profit Growth % (YoY)	-115%	-23.4%	10%	-117.6%	-307.8%	-39.7%	-16.3%	-42.7%	291.3%	11.7%	-27.6%	-23.9%	-95.5%	3%	62.2%	67.2%	2610.5%	-	-	-	-
TTM Net Profit	3.7	5.85	6.99	6.59	9.39	12.16	15.37	16.15	17.92	17.25	16.4	18.22	19.52	24.44	24.23	21.7	19.51	14.55	7.52	3.45	0
EPS in Rs	-0.75	0.7	0.9	-0.09	-0.38	1	0.82	0.49	0.18	1.66	0.98	0.85	0.05	1.49	1.35	1.12	1.06	1.44	0.84	0.67	0.04

Profit and Loss

	Mar 2026	Mar 2025	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019	Mar 2018	Mar 2017	Mar 2016	Mar 2015
Sales	374	379	367	399	333	307	278	335	273	235	269	266
Sales Growth %	-1.2%	3.2%	-7.8%	19.5%	8.5%	10.6%	-17.2%	22.9%	16.1%	-12.5%	0.8%	-
Expenses	344	335	326	347	292	268	255	293	238	203	239	278
Operating Profit	30	44	41	52	41	40	23	42	35	32	30	-12
OPM %	8	12	11	13	12	13	8	13	13	13	11	-4.4
Other Income	11	6	5	6	4	-3	5	2	9	5	-2	2
Interest	13	11	7	6	8	11	13	11	9	10	14	10
Depreciation	20	20	16	17	16	16	14	11	10	9	9	7
Profit before tax	8	18	24	35	21	10	0	22	25	18	5	-27
Tax %	29	32	27	31	31	28	-4600	30	23	-6	5	-19
Net Profit	6	12	17	24	15	7	3	15	19	19	5	-22
Net Profit Growth %	-50%	-29.4%	-29.2%	60%	114.3%	133.3%	-80%	-21.1%	-	280%	122.7%	-
EPS in Rs	1.09	2.5	3.54	5.01	2.99	1.5	0.68	3.17	0	0	0	0
Dividend Payout %	0	0	0	0	0	0	0	5	4	4	16	0

Cash Flows

	Mar 2026	Mar 2025	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019	Mar 2018	Mar 2017	Mar 2016
Cash from Operating Activity	50	41	16	38	49	32	22	35	37	32	22
Cash from Investing Activity	-55	-40	-73	-35	-14	-6	-19	-21	-26	-7	-12
Cash from Financing Activity	28	-9	60	1	-33	-26	-2	-15	-10	-25	-10
Net Cash Flow	23	-8	3	3	2	0	1	-1	1	0	0

Balance Sheet

	Mar 2026	Sep 2025	Mar 2025	Sep 2024	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019	Mar 2018	Mar 2017	Mar 2016	Mar 2015
Equity Capital	54	49	49	49	49	49	16	16	16	16	8	8	8	8
Reserves	243	203	204	194	190	152	159	145	138	135	129	110	91	86
Borrowings	127	121	118	101	112	62	53	82	90	77	81	81	96	93
Other Liabilities	116	94	102	84	96	79	112	82	82	100	81	60	61	78
Total Liabilities	539	467	472	427	447	342	342	325	325	328	298	259	256	265
Fixed Assets	162	187	164	193	161	109	106	107	116	106	94	89	92	87
CWIP	96	46	70	33	42	27	12	11	10	13	8	4	3	6
Investments	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Other Assets	282	234	237	201	244	206	224	208	200	209	196	166	161	172
Total Assets	539	467	472	427	447	342	342	325	325	328	298	259	256	265

Delivery

Delivery Data: ZIMLAB

#	Date	107 28% 137	Value (Cr)	Q/T 69	Del 62	Del 2
1	4-Sep	126	1	63	61	0
2	3-Sep	128	2	55	49	1
3	2-Sep	134	9	84	40	4
4	1-Sep	118	1	60	61	0
5	31-Aug	123	1	121	67	1
6	28-Aug	125	1	39	64	0
7	27-Aug	125	1	75	62	0
8	26-Aug	126	1	38	74	1
9	25-Aug	125	0	17	62	0
10	24-Aug	124	2	40	63	1
11	21-Aug	125	1	48	72	1
12	20-Aug	121	1	33	62	1
13	19-Aug	118	1	27	77	1
14	18-Aug	115	1	23	64	0
15	17-Aug	115	2	58	84	1

Daily Market Cap

Date	Total Market Cap	Change	Chg %
04-Sep	683c	14c	2.03
03-Sep	697c	123c	21.45
14-Aug	574c	3c	0.47
13-Aug	572c	13c	2.28
12-Aug	585c	18c	2.99
11-Aug	603c	80L	0.13
10-Aug	604c	3c	0.44
07-Aug	606c	38c	5.83
06-Aug	644c	59c	10.04
04-Aug	585c	16c	2.63
03-Aug	601c	5c	0.88
31-Jul	606c	8c	1.34
30-Jul	598c	22c	3.58
28-Jul	621c	13c	2.00
27-Jul	633c	13c	1.99
24-Jul	646c	0	0

Stock Checklist

Price is above from 52 week high low average: 91%

Stock is trading above all short term SMAs: YES

Stock is trading above all long term SMAs: YES

Stock is Consistently Improving Long Term: NO

FII purchased in last quarter: YES

Promoters are buying the stock: YES

Mutual Fund Holdings

Held by 2 fund scheme(s) across 1 fund house(s) as of Aug26 · Total value ₹14 Cr · 2 increasing / 0 decreasing · View in MF Pro →

Fund House	Schemes	Weight %	Change	Value (Cr)
Tata Mutual Fund	2	0.46%	+0.46%	14.3

Zim Laboratories Limited

Price Chart

Price Performance

Moving Average

PIVOT LEVEL

Competitors/Peers

Shareholding Pattern (%)

Quarterly Results

Profit and Loss

Cash Flows

Balance Sheet

Delivery

Daily Market Cap

Stock Checklist

Mutual Fund Holdings

Strategy Builder

Bulk Deals

Events

News

Exchange Filings

Annual Reports

Ratings & Research Reports

Concalls

Announcements